General Information of the Compound
| Compound ID |
CP0410332
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(1H-benzimidazol-2-ylmethyl)-5-(4-chlorophenyl)-1,3,4-oxadiazole
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H11ClN4O
|
||||||||||||||||||
| Molecular Weight |
310.744
|
||||||||||||||||||
| Canonical SMILES |
Clc1ccc(cc1)-c1nnc(Cc2nc3ccccc3[nH]2)o1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H11ClN4O/c17-11-7-5-10(6-8-11)16-21-20-15(22-16)9-14-18-12-3-1-2-4-13(12)19-14/h1-8H,9H2,(H,18,19)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SKURHCCLIBABGC-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01233, Receptor tyrosine-protein kinase erbB-2
Cell Viability or Cytotoxicity Assay